Provided by Tiger Fintech (Singapore) Pte. Ltd.

Supernus Pharmaceuticals

33.20
+0.15000.45%
Volume:488.74K
Turnover:16.22M
Market Cap:1.86B
PE:29.99
High:33.49
Open:32.98
Low:32.83
Close:33.05
Loading ...

Supernus Pharmaceuticals Cut to Neutral From Overweight by Cantor Fitzgerald

Dow Jones
·
19 Feb

Cantor Fitzgerald Downgrades Supernus Pharmaceuticals to Neutral From Overweight, Cuts Price Target to $36 From $57

MT Newswires Live
·
19 Feb

Stifel Nicolaus Remains a Hold on Supernus Pharmaceuticals (SUPN)

TIPRANKS
·
19 Feb

Supernus Pharma Sinks Premarket After Treatment-Resistant Depression Study Misses Primary Endpoint

MT Newswires Live
·
19 Feb

Cantor downgrades Supernus on ‘disappointing’ depression study

TIPRANKS
·
19 Feb

Supernus Shares Tumble 20% After Depression Study Misses Endpoint

Dow Jones
·
19 Feb

Supernus downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
19 Feb

BRIEF-Supernus Announces Topline Results From Phase 2B Study In Adults With Treatment Resistant Depression

Reuters
·
19 Feb

Supernus' depression treatment fails mid-stage trial

Reuters
·
19 Feb

Supernus Announces Topline Results From Phase 2B Study in Adults With Treatment Resistant Depression

THOMSON REUTERS
·
19 Feb

Supernus Pharmaceuticals Inc - Phase 2B Study of Spn-820 in Trd Fails Primary Endpoint

THOMSON REUTERS
·
19 Feb

Supernus Pharmaceuticals Inc - Spn-820 Safety Profile Consistent With Previous Trials

THOMSON REUTERS
·
19 Feb

Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Feb

Investor Optimism Abounds Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) But Growth Is Lacking

Simply Wall St.
·
10 Feb

Supernus (SUPN) Moves to Strong Buy: Rationale Behind the Upgrade

Zacks
·
07 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE) and Supernus Pharmaceuticals (SUPN)

TIPRANKS
·
05 Feb

BUZZ-Supernus rises after FDA approves its drug-device combination for Parkinson's disease

Reuters
·
05 Feb

Supernus Gets FDA Approval of Onapgo Device for Parkinson's Disease

Dow Jones
·
04 Feb

Supernus Pharmaceuticals Says Onapgo Approved by FDA for Parkinson's Disease

MT Newswires Live
·
04 Feb

U.S. FDA approves Supernus' drug-device combination for Parkinson's disease

Reuters
·
04 Feb